Role of the endoscopic treatment of vesico-ureteral reflux. A 16-years' experience;Il ruolo del trattamento endoscopico nella cura del reflusso vescico-ureterale. Esperienza di 16 anni

Minerva Pediatrica

Volumn 55, Issue 6, 2003, Pages 607-614

  Capozza, N ^a   Caione, P ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Endoscopy; Urination disorders; Vesico ureteral reflux, diagnosis; Vesico ureteral reflux, therapy

Indexed keywords

COLLAGEN IMPLANT; COPOLYMER; DIMETICONE; POLITEF; SILICONE;

ARTICLE; CHILD; ENDOSCOPIC THERAPY; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; PREOPERATIVE TREATMENT; TREATMENT OUTCOME; VESICOURETERAL REFLUX;

ADOLESCENT; ADULT; BIOCOMPATIBLE MATERIALS; CHILD; CHILD, PRESCHOOL; CYSTOSCOPY; FOLLOW-UP STUDIES; HUMANS; INFANT; TIME FACTORS; URETEROSCOPY; VESICO-URETERAL REFLUX;

EID: 0842328394     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bailey RR. Vesicoureteral reflux in healthy infants and children. In: Hodson J, Kincaid-Smith P. editors. Reflux Nephropathy. New York: Masson; 1979.p.59-61.
2. Mounger EJ, van Zile Scott E. Surgical correction of vesico-ureteral reflux. J Urol 1972;108:347-50.
3. Melhem RE, Harpen MD. Ethnic factors in the variability of primary vesico-ureteral reflux with age. Pediatr Radiol 1997;27:750-1.
4. Noe NH, Wyatt RJ, Peeden JN, Rivas ML. The transmission of vesicoureteral reflux from parent to child. J Urol 1992;148:1869-71.
5. Noe NH. The long-term results of prospective sibling reflux screening. J Urol 1992;148:1739-42.
6. Cremin BJ. Observations on vesico-ureteric reflux and intrarenal reflux: a review and survey of material. Clin Radiol 1979;30:607-21.
7. Johnston JH. Vesical diverticula without urinary obstruction in childhood. J Urol 1960;84:535-8.
8. Elder JS, Peters CA, Arant BS Jr, Ewalt DH, Hawtrey CE, Hurwitz RS et al. Pediatric vesicoureteral reflux guidelines panel summary: report on the management of primary vesicoureteral reflux in children. J Urol 1997;53:1846-51.
9. Capozza N, Caione P. Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: A randomized comparison with antibiotic prophylaxis. J Pediatr 2002;140:230-4.
10. Matouschek E. Die Behandlung des vesikorenalen Refluxes durch transurethrale Einspritzung von Teflon Paste. Urologe A 1981;20:263-4.
11. Cohen SJ. Ureterozystoneostomie. Eine neue antirefluxtechnik. Akt Urol 1975;6:1.
12. Tamminen-Möbius T, Brunier E, Ebel KD, Olbing H. Seppänen U, Sixt R on behalf of the International Reflux Study in Children (1992). Cessation of vesicoureteral reflux for 5 years on infants and children allocated to medical treatment. J Urol 1992;148:1662-6.
13. Smellie JM, Jodal U, Möbius TT, Hirche H, Olbing H. Outcome at 10 years of severe vesicoureteric reflux managed medically: Report of the International Reflux Study in Children. J Pediatr 2001;139:656-63.
14. O'Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J 1984;289: 7-9.
15. Capozza N, Caione P, Nappo S, De Gennaro M, Patricolo M. Endoscopic treatment of vesico-ureteric reflux and urinary incontinence; technical problems in the pediatric patients. Br J Urol 1995;75:538-63.
16. Vandenbossche M, Delhove O, Dumortier P, Deneft F, Schulman CC. Endoscopic treatment of reflux; experimental study and review of Teflon and collagen. Eur Urol 1993;23:386-93.
17. Miyakita H, Puri P. Particles found in lung and brain following subureteral injection of polytetrafluoroethylene paste are not Teflon particles. J Urol 1994;152:636-40.
18. Dewan PA. Is injected polytetrafluoroethylene (Polytef) carcinogenic? Br J Urol 1992;69:29-33.
19. Malizia AA, Reiman HM, Myers RP, Sande JR, Barham SS, Benson RC et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984;251:3277-81.
20. Aaronson IA. Current status of the STING: an American perspective. Br J Urol 1995;75:121-5.
21. Meli RJ, Ros PR. CT and MR appearance of subereteric Teflon and periuretral Teflon migration: a case report. Mag Res Imag 1992;10:487-90.
22. Borgatti R, Tettamanti A, Piccinelli P. Brain injury in a healthy child one year after periureteral injection of Teflon. Pediatrics 1996;98:290-1.
23. Rames RA, Aaronson IA. The migration of polytef pasto to the lung and brain following intravesical injection for the correction of reflux. Pediatr Surg Int 1991;6:239-40.
24. Preston Smith D, Kaplan WE, Ryoichi O. Evaluation of polymethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol 1994;152:1221-3.
25. Allen O. Response to subdermal implantation of textured microimplants in humans. Aesth Plast Surg 1992;16:227-30.
26. Henley DR, Barrett DM, Weiland TL, O'Connor MK, Malizia AA, Wein AJ. Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 1995;153:2039-43.
27. Rees TD, Ballantyne DL, Seidman I, Hawthorne GA. Visceral response to subcutaneous and intraperitoneal injections of silicone in mice. Plast Reconstr Surg 1967;39:402-10.
28. Dewan P, Byard RW. Histological response to injected Polytef and Bioplastique in a rat model. Br J Urol 1994;73:370-6.
29. DeLustro F, Keefe J, Fong AT, Jolivette DM. The biochemistry, biology and immunology of injectable collagens: Contigen™ Bard® collagen implant in treatment of urinary incontinence. Ped Surg Int 1991;6: 245-8.
30. Frey P, Lutz N, Berger D, Herzog B. Histological behavior of glutaraldehyde cross-linked bovine collagen into the human bladder for the treatment fo vesicoureteral reflux. J Urol 1994;152:632-5.
31. Cooperman L, Michaeli D. The immunogenicity of injectable collagen: II. A retrospective review of seventy-two tested and treated patients. J Am Acad Dermatol 1984;10:647-51.
32. Cukier J, Beauchamp RA, Spindler JS, Sindler S, Lorenzo C, Trentham DE. Association between bovine collagen dermal implants and a dermatomyositis or polymyositis-like syndrome. Ann Intern Med 1993; 118:920-8.
33. Lipsky H, Würnschimmel E. Endoscopic treatment of vesicoureteric reflux with collagen. Five years experience. Br J Urol 1993;72:965-8.
34. Stenberg A, Läckgren G. A new bioimplant Deflux® System for the endoscopic treatment for vesicoureteral reflux. Experimental and clinical results. J Urol 1995;154:800-3.
35. Stenberg AM, Laarson E, Lindholm A, Ronnaeus B, Stenberg A, Läckgren G. Experimental studies of an injectable dextranomer-based implant. Histopathology, volume changes and DNA analysis. In: Postmenopausal disorders with special reference to urinary incontinence. Acta Universitatis Uppsaliensis. Dissertation 1998;3:1-15.
36. Stenberg AM, Sundin A, Laarson E, Läckgren G, Stenberg A. Lack of distant migration after injection of 25 Iodine-labelled dextranomer based implant into rabbit bladder. J Urol 1997;158:1937-41.
37. Riedmiller H, Androulakakis P, Beurton D, Kocvara R, Gerharz E. EAU guidelines on paediatric urology. Eur Urol 2001;40:589-99.
38. Arant BS. Vesicoureteral reflux and evidence-based management. J Pediatr 2001;139:620-1.
39. Capozza N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P. Influence of voiding dysfunction on the outcome of endoscopic treatment for vesico-ureteral reflux. J Urol 2002;168(4 Pt 2):1695-8.